共 181 条
[1]
Delmas PD(2002)Treatment of postmenopausal osteoporosis Lancet 359 2018-2026
[2]
Riggs BL(2005)Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling J Bone Miner Res 20 177-184
[3]
Parfitt AM(2003)Strontium ranelate: a new paradigm in the treatment of osteoporosis Drugs Today 39 89-101
[4]
Reginster J-Y(2004)The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 459-468
[5]
Deroisy R(2005)Strontium ranelate reduces the risk of non vertebral fractures in postmenopausal women with osteoporosis: TROPOS study J Clin Endocrinol Metab 90 2816-2822
[6]
Jupsin I(2002)Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice Metabolism 51 906-911
[7]
Meunier PJ(2004)Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats J Bone Miner Res 19 2012-2020
[8]
Roux C(2001)Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys ( Bone 29 176-179
[9]
Seeman E(1993)) J Bone Miner Res 8 607-615
[10]
Ortolani S(1996)An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats Bone 18 253-259